Please login to the form below

Not currently logged in
Email:
Password:

Hanover Brussels appoints Aurélie Marchand as account director

She joins the communications consultancy from Hill & Knowlton Strategies Paris

Aurelie MarchlandHanover Brussels has bolstered its policy team with a new senior hire in the form of Aurélie Marchand, who joins the communications and public affairs consultancy as its EU health account director.

She joins the group from Hill & Knowlton Strategies Paris, where she spent the past six years as its public affairs lead advising healthcare and FMCG clients.

Marchand said: “I am extremely honoured to join such a renowned and forward-thinking agency.

“Coming from a country where market access and negotiations around pricing and reimbursement can be challenging, I’m eager to bring this experience to the EU level.”

Prior to Hill & Knowlton, Marchand served Sanofi, where she worked on French Parliament relations and she has held several positions within the French administration working for general secretariat for European affairs and the Ministry of Immigration.

Emma Eatwell, director of EU healthcare, Hanover, said: “With her [Marchand] wealth of experience at both national and European level, she will be an excellent addition to our team and will be instrumental in continuing the growth of our business.”

In her new role, Marchand will report to Eatwell and she will oversee the group’s portfolio of clients, which includes Sanofi Pasteur and Vertex Pharmaceuticals.

19th November 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need...
JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...